251 related articles for article (PubMed ID: 10512853)
21. Caldesmon and the regulation of cytoskeletal functions.
Wang CL
Adv Exp Med Biol; 2008; 644():250-72. PubMed ID: 19209827
[TBL] [Abstract][Full Text] [Related]
22. Disruption of the actin cytoskeleton in living nonmuscle cells by microinjection of antibodies to domain-3 of caldesmon.
Lamb NJ; Fernandez A; Mezgueldi M; Labbé JP; Kassab R; Fattoum A
Eur J Cell Biol; 1996 Jan; 69(1):36-44. PubMed ID: 8825022
[TBL] [Abstract][Full Text] [Related]
23. Changes in cytoskeletal organization in polyoma middle T antigen-transformed fibroblasts: involvement of protein phosphatase 2A and src tyrosine kinases.
da Costa SR; Wang Y; Vilalta PM; Schönthal AH; Hamm-Alvarez SF
Cell Motil Cytoskeleton; 2000 Dec; 47(4):253-68. PubMed ID: 11093247
[TBL] [Abstract][Full Text] [Related]
24. Genetic ablation of zyxin causes Mena/VASP mislocalization, increased motility, and deficits in actin remodeling.
Hoffman LM; Jensen CC; Kloeker S; Wang CL; Yoshigi M; Beckerle MC
J Cell Biol; 2006 Feb; 172(5):771-82. PubMed ID: 16505170
[TBL] [Abstract][Full Text] [Related]
25. [C-terminal sites of caldesmon drive ATP hydrolysis cycle by shifting actomyosin itermediates from strong to weak binding of myosin and actin].
Pronina OE; Copeland O; Marston S; Borovikov IuS
Tsitologiia; 2006; 48(1):9-18. PubMed ID: 16568830
[TBL] [Abstract][Full Text] [Related]
26. RhoJ/TCL regulates endothelial motility and tube formation and modulates actomyosin contractility and focal adhesion numbers.
Kaur S; Leszczynska K; Abraham S; Scarcia M; Hiltbrunner S; Marshall CJ; Mavria G; Bicknell R; Heath VL
Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):657-64. PubMed ID: 21148427
[TBL] [Abstract][Full Text] [Related]
27. Anti-caldesmon monoclonal antibody reverses the inhibition of actomyosin Mg(2+)-ATPase activity by caldesmon.
Abe M; Mizuno T; Nishida W; Hiwada K
Biochem Int; 1992 Oct; 28(2):249-54. PubMed ID: 1280950
[TBL] [Abstract][Full Text] [Related]
28. Caldesmon-dependent switching between capillary endothelial cell growth and apoptosis through modulation of cell shape and contractility.
Numaguchi Y; Huang S; Polte TR; Eichler GS; Wang N; Ingber DE
Angiogenesis; 2003; 6(1):55-64. PubMed ID: 14517405
[TBL] [Abstract][Full Text] [Related]
29. Reciprocal regulation of actomyosin organization and contractility in nonmuscle cells by tropomyosins and alpha-actinins.
Hu S; Grobe H; Guo Z; Wang YH; Doss BL; Pan M; Ladoux B; Bershadsky AD; Zaidel-Bar R
Mol Biol Cell; 2019 Jul; 30(16):2025-2036. PubMed ID: 31216217
[TBL] [Abstract][Full Text] [Related]
30. Neuromedin B receptor activation causes tyrosine phosphorylation of p125FAK by a phospholipase C independent mechanism which requires p21rho and integrity of the actin cytoskeleton.
Tsuda T; Kusui T; Jensen RT
Biochemistry; 1997 Dec; 36(51):16328-37. PubMed ID: 9405068
[TBL] [Abstract][Full Text] [Related]
31. Calyculin-A induces focal adhesion assembly and tyrosine phosphorylation of p125(Fak), p130(Cas), and paxillin in Swiss 3T3 cells.
Leopoldt D; Yee HF; Rozengurt E
J Cell Physiol; 2001 Jul; 188(1):106-19. PubMed ID: 11382927
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies against caldesmon, a Ca++/calmodulin- and actin-binding protein of smooth muscle and nonmuscle cells.
Lin JJ; Lin JL; Davis-Nanthakumar EJ; Lourim D
Hybridoma; 1988 Jun; 7(3):273-88. PubMed ID: 3294163
[TBL] [Abstract][Full Text] [Related]
33. Caldesmon and low Mr isoform of tropomyosin are localized in neuronal growth cones.
Kira M; Tanaka J; Sobue K
J Neurosci Res; 1995 Feb; 40(3):294-305. PubMed ID: 7745623
[TBL] [Abstract][Full Text] [Related]
34. Caldesmon inhibits the rotation of smooth actin subdomain-1 and alters its mobility during the ATP hydrolysis cycle.
Kulikova N; Avrova SV; Borovikov YS
Biochem Biophys Res Commun; 2009 Dec; 390(1):125-9. PubMed ID: 19782047
[TBL] [Abstract][Full Text] [Related]
35. Modulation of actomyosin ATPase by thin filament-associated proteins.
Chacko S; Miyata H; Horiuchi KY
Prog Clin Biol Res; 1987; 245():143-58. PubMed ID: 2960977
[TBL] [Abstract][Full Text] [Related]
36. Rho-kinase dependent organization of stress fibers and focal adhesions in cultured fibroblasts.
Katoh K; Kano Y; Ookawara S
Genes Cells; 2007 May; 12(5):623-38. PubMed ID: 17535253
[TBL] [Abstract][Full Text] [Related]
37. Characterization of smooth muscle caldesmon as a microtubule-associated protein.
Ishikawa R; Kagami O; Hayashi C; Kohama K
Cell Motil Cytoskeleton; 1992; 23(4):244-51. PubMed ID: 1477888
[TBL] [Abstract][Full Text] [Related]
38. Epitope mapping of monoclonal antibodies against caldesmon and their effects on the binding of caldesmon to Ca++/calmodulin and to actin or actin-tropomyosin filaments.
Lin JJ; Davis-Nanthakumar EJ; Jin JP; Lourim D; Novy RE; Lin JL
Cell Motil Cytoskeleton; 1991; 20(2):95-108. PubMed ID: 1721558
[TBL] [Abstract][Full Text] [Related]
39. Caldesmon is a cytoskeletal target for PKC in endothelium.
Bogatcheva NV; Birukova A; Borbiev T; Kolosova I; Liu F; Garcia JG; Verin AD
J Cell Biochem; 2006 Dec; 99(6):1593-605. PubMed ID: 16823797
[TBL] [Abstract][Full Text] [Related]
40. Caldesmon, a novel regulatory protein in smooth muscle and nonmuscle actomyosin systems.
Sobue K; Sellers JR
J Biol Chem; 1991 Jul; 266(19):12115-8. PubMed ID: 2061300
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
